title: Psychopharmacology of autism spectrum disorders.
abstract: At present, no evidence-based effective pharmacologic options are available for treating the core deficits of autism spectrum disorders (ASDs), which are best addressed by behavioral and educational interventions. However, such evidence exists for several of the frequently associated/comorbid symptoms such as aggression and severe irritability, hyperactivity, and repetitive behaviors, which can become a major source of additional distress and interference in functioning. This article offers information on the psychopharmacology of ASD that is current, relevant, and organized in a user-friendly manner, to form a concise but informative reference guide for primary pediatric clinicians.
authors.affiliation: Department of Psychiatry, Hoboken University Medical Center, 308 Willow Avenue, Hoboken, NJ 07030, USA. drgkaplan@gmail.com
authors.forename: Gabriel
authors.initials: G
authors.lastname: Kaplan
authors.forename: James T
authors.initials: JT
authors.lastname: McCracken
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy* / Q000523:psychology*; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D011569:Psychiatric Status Rating Scales; D011600:Psychopharmacology / Q000379:methods*
chemical_list: D014150:Antipsychotic Agents